322. A RANDOMISED, DOUBLE-BLIND, CONTROLLED, MECHANISTIC STUDY OF RITUXIMAB AND BELIMUMAB COMBINATION THERAPY IN PR3 ANCA-ASSOCIATED VASCULITIS (COMBIVAS): STUDY PROTOCOL

Authors :: Robert B Henderson
Alan D. Salama
David Jayne
Antonella Napolitano Rosen
James Wason
Seerapani Gopaluni
Rachel B Jones
Mark McClure
Charles D. Pusey
Source :: Rheumatology. 58
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: Oncology
Protocol (science)
medicine.medical_specialty
Randomization
Combination therapy
business.industry
ANCA-Associated Vasculitis
Belimumab
Double blind
Rheumatology
Internal medicine
medicine
Combined Modality Therapy
Pharmacology (medical)
Rituximab
business
medicine.drug

Full Text Access

Tools